Sectors
QNRX
Quoin Pharmaceuticals, Ltd.
6.22
10 x 6.28
1 x 7.50
bid
ask
+
0.10
1.63%
6 @ 05:54 PM
5.93 -0.29 (4.66%)
| Ytd | -56.90% | |
| 1y | -15.72% |
5.43
day range
6.55
3.25
52 week range
41.80
| Open | 5.45 | Prev Close | 6.12 | Low | 5.43 | High | 6.55 | Mkt Cap | 12.49M |
| Vol | 565.71K | Avg Vol | 728.17K | EPS | -5.67 | P/E | N/A | Forward P/E | -0.43 |
| Beta | 1.89 | Short Ratio | 0.20 | Inst. Own | 5.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 4.67 | 200-d Avg | 8.12 | 1yr Est | 4.50 |
| Income Statement | |||
| Operating Expenses | 5.47M | ||
| Research and Development Expense | 3.63M | ||
| Selling, General and Administrative Expense | 1.85M | ||
| Operating Income | -5.47M | ||
| Net Income | -5.37M | ||
| Net Income Common Stock | -5.37M | ||
| Net Income Common Stock (USD) | -5.37M | ||
| Consolidated Income | -5.37M | ||
| Earning Before Interest & Taxes (EBIT) | -5.37M | ||
| Earning Before Interest & Taxes (USD) | -5.37M | ||
| Weighted Average Shares | 70.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.85M | ||
| Cash and Equivalents (USD) | 3.85M | ||
| Investments | 6.95M | ||
| Investments Current | 6.95M | ||
| Current Assets | 11.64M | ||
| Total Assets | 11.97M | ||
| Current Liabilities | 6.61M | ||
| Total Liabilities | 8.04M | ||
| Accumulated Retained Earnings (Deficit) | -81.34M | ||
| Accumulated Other Comprehensive Income | -582.00 | ||
| Shareholders Equity | 3.93M | ||
| Shareholders Equity (USD) | 3.93M | ||
| Assets Non-Current | 333.33K | ||
| Goodwill and Intangible Assets | 333.33K | ||
| Liabilities Non-Current | 1.42M | ||
| Trade and Non-Trade Payables | 3.11M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.00K | ||
| Net Cash Flow from Financing | -151.95K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 721.08K | ||
| Issuance (Purchase) of Equity Shares | -1.95K | ||
| Issuance (Repayment) of Debt Securities | -150.00K | ||
| Net Cash Flow from Investing | 4.02M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.02M | ||
| Net Cash Flow from Operations | -3.14M | ||
| Effect of Exchange Rate Changes on Cash | -423.00 | ||
| Share Based Compensation | 532.95K | ||